Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PHK vs NCV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PHK Wins Head-to-Head Institutional Verdict (1–0 across 6 Pillars · 3–1 Matrix Metrics)

PHK Overall Winner 6-Pillar Tally: PHK 1 – 0 NCV (5 Tie) Matrix Metrics: PHK 3 – 1 NCV

As of Nov 16, 2026, PIMCO High Income Fund (PHK) is the stronger overall head-to-head candidate over Virtus Convertible & Income Fund (NCV) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). PHK carries a Unified Composite Score of 35.4/100 (SELL) at $3.99 (N/M Forward P/E, N/A operating margin), whereas NCV carries 35.9/100 (SELL) at $13.91 (N/M Forward P/E, N/A operating margin).

  • Defensive Composite Rating Caution: Although PHK compares more favorably head-to-head, both PHK (35.4/100 SELL) and NCV (35.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
  • Technical & Structure Timing Caution: PHK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile NCV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PHK vs NCV
PHK NYSE Head-to-Head Winner
PIMCO High Income Fund
Institutional Equity
$3.99
-0.5% 1D
Market Cap $866.7M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.47β · 16% Vol
Unified Composite Score
35.4 / 100 SELL
Tech 34.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 39
RSI-14: 38.6 · SMA20: $4.09 · SMA50: $4.16
NCV NYSE
Virtus Convertible & Income Fund
Institutional Equity
$13.91
-2.93% 1D
Market Cap $341.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.84β · 22% Vol
Unified Composite Score
35.9 / 100 SELL
Tech 7.0 Fund 41.0 Flow 50.0 Mom 69.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.9%), weak momentum, RSI 29
RSI-14: 28.9 · SMA20: $14.88 · SMA50: $15.26

6-Pillar Scorecard Institutional Category Breakdown (PHK 1 – 0 NCV)

Columns: Metric · PHK · NCV
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale PHK
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap $866.7M $341.2M
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PHK (3) vs NCV (1)
Institutional Metric PHK NCV Criterion Row Edge
Market Capitalization
Scale
$866.7M $341.2M Larger Scale PHK
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
4% ($4–$5) 2% ($14–$18) Stronger Trend PHK
Beta / 30D Volatility
Risk Regime
0.47β · 16% Vol 0.84β · 22% Vol Lower Realized Risk PHK
Unified Institutional Score
Composite Signal
35.4 / 100 (SELL) 35.9 / 100 (SELL) Higher Composite NCV
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PHK +3.92 pp
PHK: -1.97% · NCV: -5.89%
3M Horizon PHK +4.84 pp
PHK: -12.31% · NCV: -17.15%
6M Horizon PHK +5.63 pp
PHK: -11.92% · NCV: -17.55%
1Y Horizon NCV +9.02 pp
PHK: -17.39% · NCV: -8.37%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PHK vs NCV. Trailing 12-month operating profitability (PHK N/A vs NCV N/A) and valuation multiples (PHK N/M vs NCV N/M Forward P/E) are benchmarked directly in Pillar 4 below.

PHK ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
NCV ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PHK UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact PHK Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NCV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NCV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PHK Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $866.7M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
NCV Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with $341.2M market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PHK vs NCV Key Questions & Quantitative Answers

As of Nov 16, 2026, PIMCO High Income Fund (PHK) is the stronger overall head-to-head candidate over Virtus Convertible & Income Fund (NCV) in the Tradestie Institutional Equity Comparison Engine, winning 3–1 core matrix metrics and 1–0 across our 6-pillar institutional scorecard (led by Growth & Scale). PHK carries a Unified Composite Score of 35.4/100 (SELL) at $3.99 (N/M Forward P/E, N/A operating margin), whereas NCV carries 35.9/100 (SELL) at $13.91 (N/M Forward P/E, N/A operating margin). Defensive Composite Rating Caution: Although PHK compares more favorably head-to-head, both PHK (35.4/100 SELL) and NCV (35.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: PHK is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.6); meanwhile NCV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

PHK leads the Growth & Scale pillar: PHK posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with NCV at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, PHK generates N/A in USD-normalized revenue versus N/A for NCV. In operating R&D and SG&A reinvestment, PHK deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NCV.

PHK and NCV trade at balanced relative valuation multiples. PHK trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas NCV trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PHK (N/A ROE) versus NCV (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, PHK carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.47β · 16% Vol realized risk). By comparison, NCV carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.84β · 22% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.